Spotlights on Recent JACS Publications

摘要

Haiyen Zhau, Bogdan Olenyuk, Jean Shih, and colleagues have designed a monoamine oxidase A inhibitor-near-infrared dye conjugate that holds promise for targeting and treating tumors in prostate cancer (DOI: 10.1021/ja5126l3j). Prostate cancer is the second leading cause of cancer-related deaths for men in the U.S., but most current treatments such as chemotherapy, radiation therapy, and surgery, are only effective for patients with its early stages and significantly decrease their quality of life. The search for new therapies to effectively combat prostate tumors of all grades is an ongoing, multidisciplinary endeavor.